Danske Bank A/S

Institutional investor · Portfolio as of Q2 2026

Top Holdings1,158 positions

Checking export access…
Activity:
NVDA

NVIDIA Corporation

18M$3.6B7.1%$105.90+76.24%
10 qtrssince 2024-Q1
Decreased
0
AAPL

Apple Inc.

11.1M$3.2B6.3%$198.21+72.73%
10 qtrssince 2024-Q1
Decreased
0
AMZN

Amazon.com, Inc.

10.5M$2.5B4.9%$197.87+31.05%
10 qtrssince 2024-Q1
Increased
64
MSFT

Microsoft Corporation

5.7M$2.1B4.2%$418.00+26.94%
10 qtrssince 2024-Q1
Increased
59
GOOGL

Alphabet Inc.

5.2M$1.8B3.6%$173.63+64.01%
10 qtrssince 2024-Q1
Increased
64
AVGO

Broadcom Inc.

3.3M$1.2B2.4%$177.10+65.83%
10 qtrssince 2024-Q1
Increased
55
GOOG

Alphabet Inc.

3.3M$1.2B2.3%$186.89+51.92%
10 qtrssince 2024-Q1
Increased
61
AMD

Advanced Micro Devices, Inc.

1.9M$1.1B2.2%$359.99+24.74%
10 qtrssince 2024-Q1
Increased
84
MU

Micron Technology, Inc.

911,561$1.1B2.1%$145.74+373.43%
10 qtrssince 2024-Q1
Decreased
0
META

Meta Platforms, Inc.

1.7M$938.1M1.9%$533.00+14.47%
10 qtrssince 2024-Q1
Increased
52
LLY

Eli Lilly and Company

767,326$920.4M1.8%$795.69+70.17%
10 qtrssince 2024-Q1
Increased
50
TSLA

Tesla, Inc.

2.2M$907.6M1.8%$273.23+31.11%
10 qtrssince 2024-Q1
Increased
56
JPM

JPMorgan Chase & Co.

2.4M$779.5M1.5%$215.73+55.05%
10 qtrssince 2024-Q1
Increased
52
V

Visa Inc.

1.7M$597.9M1.2%$299.29+41.22%
10 qtrssince 2024-Q1
Decreased
0
BRK/B

Berkshire Hathaway Inc.

1.1M$530.9M1.0%$449.17+27.10%
10 qtrssince 2024-Q1
Increased
63
JNJ

Johnson & Johnson

2.1M$527M1.0%$152.98+80.56%
10 qtrssince 2024-Q1
Increased
49
WMT

Walmart Inc.

4.2M$475.4M0.9%$82.68+51.82%
10 qtrssince 2024-Q1
Increased
59
LRCX

Lam Research Corporation

954,179$413.5M0.8%$78.57+155.10%
7 qtrssince 2024-Q4
Decreased
0
CSCO

Cisco Systems, Inc.

3.3M$386.6M0.8%$50.37+86.32%
10 qtrssince 2024-Q1
Decreased
0
INTC

Intel Corporation

2.7M$383.5M0.8%$41.60+35.30%
10 qtrssince 2024-Q1
Increased
47
$50.6B
AUM
1,158
Positions
Q2 2026
Filing
HI rating · 2.5/5
Quarterly 13F Value Change
Reported 13F value ($B)
Reported 13F values and quarter-over-quarter reported value changes; not investment returns.
QuarterReported value in US dollarsReported value change
2025-Q1$32,737,263,162-2.12568415098%
2025-Q2$40,264,729,78422.9935733624%
2025-Q3$40,214,434,826-0.124910705399%
2025-Q4$42,999,054,9806.92442941458%
2026-Q1$41,511,520,356-3.45945887576%
2026-Q2$50,580,693,09321.847363477%
Activity profile
$ moved · Q2'26
New2%Increased63%Decreased34%Exited2%
Composition
Equity vs derivatives
Equity99%Puts0%Calls1%
Holding period
Avg 1.8 years
<1Q3%1-4Q10%1-2Y20%2Y+66%

Danske Bank A/S manages $50.6B across 1158 positions as of Q2 2026. Top holdings: NVDA (7.1%), AAPL (6.3%), AMZN (4.9%). Fund DNA: Balanced Allocator. HoldingsIntel Score: 2.5/5.0.

Q2 2026 Summary

Active quarter - 42 new positions, 74 exits, 359 increased. Top move: AMD (INCREASED, conviction 84). Portfolio: $50.6B across 1158 positions.

Top holdings by portfolio weight

Total AUM$50B
NVDA7.12%
AAPL6.33%
AMZN4.93%
MSFT4.17%
GOOGL3.65%
AVGO2.44%
GOOG2.33%
AMD2.19%
MU2.08%
META1.85%
Other1.82%

Portfolio allocation by GICS sector

Sectors11
Technology38.89%
Financial Services12.33%
Consumer Cyclical10.54%
Communication Services10.19%
Healthcare9.44%
Industrials7.89%
Consumer Defensive4.06%
Basic Materials2.01%
Real Estate1.89%
Utilities1.43%
Other1.34%

Behavioral investing profile

Checking access…
Balanced Allocator- primarily Technology, Financial Services, Consumer Cyclical
Compare DNA across all funds
7-dimension, SEC 13F-derived research score
Solid(2.5 / 5.0)
Holdings P&L46
Conviction47
Concentration56
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
7Q
REGREGRegency Centers Corporation
Q4 2024 → Q2 2026+158,570 shares+$13.2M
7Q
BAPBAPCredicorp Ltd.
Q4 2024 → Q2 2026+17,680 shares+$10.1M
7Q
RPRXRPRXRoyalty Pharma plc
Q4 2024 → Q2 2026+510,719 shares+$35.7M
Checking access…

Famous Investors' Portfolios

What the most-followed managers hold, and what they bought and sold each quarter.

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Verify source filings on SEC EDGAR

Optional analytics helps us improve. How it’s used